| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NONE | Class I Common Stock | Award | +186K | +296.4% | 248K | Oct 1, 2021 | By Streiff Family Trust UA DTD 03/26/2013 | F1, F2 | ||
| transaction | NONE | Class I Common Stock | Award | +20.6K | 20.6K | Oct 1, 2021 | By Griffin-American Healthcare REIT III Advisor, LLC | F1, F3 | |||
| transaction | NONE | Class I Common Stock | Other | -$190K | -20.6K | -100% | $9.22* | 0 | Oct 1, 2021 | By Griffin-American Healthcare REIT III Advisor, LLC | F4 |
| transaction | NONE | Class T Common Stock | Other | -$192K | -20.8K | -100% | $9.22* | 0 | Oct 1, 2021 | By Griffin-American Healthcare REIT IV Advisor, LLC | F5 |
| transaction | NONE | Class T Common Stock | Award | $0 | +69.1K | $0.00 | 69.1K | Oct 4, 2021 | Direct | F6 | |
| holding | NONE | Class T Common Stock | 47.8K | Oct 1, 2021 | By Streiff Family Trust UA DTD 03/26/2013 | F2 |
| Id | Content |
|---|---|
| F1 | Reflects the acquisition of shares of the Issuer's common stock in connection with the merger (the "Merger") of Griffin-American Healthcare REIT III, Inc. ("GAHR III") with and into Continental Merger Sub, LLC, a wholly-owned subsidiary of American Healthcare REIT, Inc. ("AHR"). In the Merger, each share of GAHR III's common stock, par value $0.01 per share, was converted into the right to receive 0.9266 shares of the Issuer's Class I common stock, par value $0.01 per share ("AHR Class I Common Stock"). There is no established market for shares of AHR Class I Common Stock. On March 18, 2021, the board of directors of AHR approved an estimated value per share of AHR Class I Common Stock of $9.22. |
| F2 | The reported shares of common stock are held directly by Streiff Family Trust UA DTD 03/26/2013, and indirectly by Mathieu B. Streiff, Trustee. |
| F3 | The reported shares of common stock are owned by Griffin-American Healthcare REIT III Advisor, LLC ("GAHRIII Advisor"), which is 75% owned and managed by wholly owned subsidiaries of American Healthcare Investors, LLC ("American Healthcare Investors"). Mr. Streiff serves as a managing director of American Healthcare Investors, and as such, may be deemed to be the beneficial owner of such common stock. Mr. Streiff disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. |
| F4 | In connection with the Merger, after the shares of common stock owned by GAHRIII Advisor were converted into the right to receive AHR Class I Common Stock pursuant to footnote (1) above, the shares owned by GAHRIII Advisor were then redeemed by the Issuer for $9.22 per share. GAHRIII Advisor is 75% owned and managed by wholly owned subsidiaries of American Healthcare Investors. Mr. Streiff serves as a managing director of American Healthcare Investors, and as such, may be deemed to have been the beneficial owner of such common stock. Mr. Streiff disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. |
| F5 | In connection with the Merger, the shares owned by Griffin-American Healthcare REIT IV Advisor, LLC ("GAHRIV Advisor") were redeemed by the Issuer for $9.22 per share. Mr. Streiff serves as a managing director of American Healthcare Investors, the managing member of GAHRIV Advisor, and as such, may be deemed to have been the beneficial owner of such common stock. Mr. Streiff disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. |
| F6 | The Reporting Person was granted 69,143 shares of restricted Class T common stock on October 4, 2021. The shares of restricted Class T common stock vest in three equal annual installments on October 1, 2022, October 1, 2023 and October 1, 2024 (subject to continuous employment through each vesting date). |